Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF".

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Fordyce, CB; Piccini, JP; Patel, MR

Published Date

  • November 29, 2016

Published In

Volume / Issue

  • 134 / 22

Start / End Page

  • e532 - e533

PubMed ID

  • 27895028

Pubmed Central ID

  • 27895028

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.116.025258

Language

  • eng

Conference Location

  • United States